Using a panel of ovarian cancer cell lines and orthotopic mouse models of ovarian cancer, we would like to demonstrate that the level of GDF15 expression induced by chemotherapeutic agents is p53-dependent and that up-regulation of secretory GDF15 protein by treatment with cisplatin can be detected in the mouse sera. This evidence concerns the gene TP53 and ovarian carcinoma.